Literature DB >> 25049358

Vector-encoded Helicobacter pylori neutrophil-activating protein promotes maturation of dendritic cells with Th1 polarization and improved migration.

Mohanraj Ramachandran1, Chuan Jin1, Di Yu1, Fredrik Eriksson1, Magnus Essand2.   

Abstract

Helicobacter pylori neutrophil-activating protein (HP-NAP) is a major virulence factor involved in H. pylori infection. Both HP-NAP protein and oncolytic viruses encoding HP-NAP have been suggested as immunotherapeutic anticancer agents and adjuvants for vaccination but with little known about its mode of action to activate adaptive immunity. Dendritic cells (DCs) are key players in bridging innate and adaptive immune responses, and in this study we aim to evaluate the effect of HP-NAP on DC maturation, migration, and induction of adaptive immune response. Maturation markers CD83, CD80, CD86, HLA-DR, CD40, and CCR7 were upregulated on human DCs after treatment with supernatants from HP-NAP adenovirus-infected cells. HP-NAP-activated DCs had a Th1 cytokine secretion profile, with high IL-12 and relatively low IL-10 secretion, and migrated toward CCL19. Ag-specific T cells were efficiently expanded by Ag-presenting HP-NAP-activated DCs, which is an important property of functionally mature DCs. Furthermore, intradermal injections of HP-NAP-encoding adenovirus in C57BL/6 mice enhanced resident DC migration to draining lymph nodes, which was verified by imaging lymph nodes by two-photon microscopy and by phenotyping migrating cells by flow cytometry. In conclusion, therapeutic effects of HP-NAP are mediated by maturation of DCs and subsequent activation of Ag-specific T cells in addition to provoking innate immunity.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25049358     DOI: 10.4049/jimmunol.1400339

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

Review 1.  HP-NAP of Helicobacter pylori: The Power of the Immunomodulation.

Authors:  Gaia Codolo; Sara Coletta; Mario Milco D'Elios; Marina de Bernard
Journal:  Front Immunol       Date:  2022-06-29       Impact factor: 8.786

2.  Germline mutations and blood malignancy (Review).

Authors:  Yuping Gong; Jili Deng; Xia Wu
Journal:  Oncol Rep       Date:  2020-11-11       Impact factor: 3.906

3.  CAR T cells expressing a bacterial virulence factor trigger potent bystander antitumour responses in solid cancers.

Authors:  Chuan Jin; Jing Ma; Mohanraj Ramachandran; Di Yu; Magnus Essand
Journal:  Nat Biomed Eng       Date:  2022-04-04       Impact factor: 29.234

4.  Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy.

Authors:  I D Iankov; C B Kurokawa; A B D'Assoro; J N Ingle; E Domingo-Musibay; C Allen; C M Crosby; A A Nair; M C Liu; I Aderca; M J Federspiel; E Galanis
Journal:  Cancer Gene Ther       Date:  2015-08-14       Impact factor: 5.987

5.  Characterization of the murine myeloid precursor cell line MuMac-E8.

Authors:  Stephan Fricke; Cathleen Pfefferkorn; Doris Wolf; Sina Riemschneider; Janine Kohlschmidt; Nadja Hilger; Christiane Fueldner; Jens Knauer; Ulrich Sack; Frank Emmrich; Jörg Lehmann
Journal:  PLoS One       Date:  2014-12-29       Impact factor: 3.240

6.  Differential effects of DEAE negative mode chromatography and gel-filtration chromatography on the charge status of Helicobacter pylori neutrophil-activating protein.

Authors:  Zhi-Wei Hong; Yu-Chi Yang; Timothy Pan; Huey-Fen Tzeng; Hua-Wen Fu
Journal:  PLoS One       Date:  2017-03-22       Impact factor: 3.240

Review 7.  Helicobacter pylori infection: An overview of bacterial virulence factors and pathogenesis.

Authors:  Cheng-Yen Kao; Bor-Shyang Sheu; Jiunn-Jong Wu
Journal:  Biomed J       Date:  2016-04-01       Impact factor: 4.910

8.  Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma models.

Authors:  Grammatiki Fotaki; Chuan Jin; Iliana Kyriaki Kerzeli; Mohanraj Ramachandran; Minttu-Maria Martikainen; Alex Karlsson-Parra; Di Yu; Magnus Essand
Journal:  Oncoimmunology       Date:  2017-12-26       Impact factor: 8.110

9.  Production and delivery of Helicobacter pylori NapA in Lactococcus lactis and its protective efficacy and immune modulatory activity.

Authors:  Xiaoyan Peng; Rongguang Zhang; Guangcai Duan; Chen Wang; Nan Sun; Linghan Zhang; Shuaiyin Chen; Qingtang Fan; Yuanlin Xi
Journal:  Sci Rep       Date:  2018-04-24       Impact factor: 4.379

10.  Helicobacter pylori is associated with weakened pulmonary function and reduced incidence of allergic conditions in patients with chronic cough.

Authors:  Meng He; Yuanyuan Zheng; A'Huo Ma; Chunyi Zhang; Yuefang Yu; Hua Wang; Yefeng Chen; Min Xiang; Kelong Tao; Juxin Shen
Journal:  Exp Ther Med       Date:  2020-09-03       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.